News from veracyte A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 03, 2016, 16:05 ET Veracyte Announces Second Quarter 2016 Financial Results

Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the second quarter ended June 30, 2016 and provided an update on recent...


Jul 12, 2016, 08:00 ET Veracyte to Host Conference Call and Webcast to Discuss Second Quarter 2016 Financial Results on Wednesday, August 3, 2016

 Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its second quarter 2016 financial results after close of market on...


Jun 30, 2016, 08:00 ET Veracyte to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie Anderson, president and chief executive officer, will present at the Cantor...


Jun 27, 2016, 07:30 ET Veracyte Named a San Francisco Bay Area 2016 "Top Workplace"

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has been...


Jun 17, 2016, 18:51 ET Veracyte Releases Statement on CMS's Final PAMA Rule

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, issued the following statement in...


Jun 13, 2016, 16:05 ET Veracyte Announces Resignation of Its Chief Financial Officer

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the resignation of...


Jun 10, 2016, 21:45 ET Veracyte Statement on CMS's Preliminary Gapfill Rate for the Afirma® Gene Expression Classifier

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today issued the statement below on...


Jun 01, 2016, 08:00 ET Veracyte to Present at the William Blair & Company 36th Annual Growth Stock Conference

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Chris Hall, chief operating officer, will present at the William Blair & Company 36th...


May 27, 2016, 07:30 ET Veracyte Announces New Data that Advance Understanding of the Role of Gene Alterations In Thyroid Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced findings from two...


May 23, 2016, 07:30 ET Veracyte Announces Data from Multiple Studies Advancing Scientific Understanding of Thyroid Cancer to Be Presented at AACE Congress

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that company...


May 17, 2016, 17:30 ET New Data Demonstrating Ability of Veracyte's Genomic Test to Improve Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2016

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced findings from a new study...


May 17, 2016, 17:15 ET New Data Suggesting Veracyte's Percepta® Bronchial Genomic Classifier Can Reduce Unnecessary Invasive Procedures In Lung Cancer Diagnosis Presented at ATS 2016

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that new data suggesting...


May 05, 2016, 16:05 ET Veracyte Announces First Quarter 2016 Financial Results

Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the first quarter ended March 31, 2016 and provided an update on recent...


Apr 19, 2016, 12:01 ET Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2016 Financial Results on Thursday, May 5, 2016

 Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its first quarter 2016 financial results after close of market on Thursday,...


Apr 02, 2016, 13:15 ET Clinical Utility of Veracyte's Afirma® Gene Expression Classifier Demonstrated in Multiple Studies Presented at ENDO 2016

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced findings from two new...


Mar 29, 2016, 16:05 ET Multiple Studies Showcasing Clinical Utility of Veracyte's Afirma® Gene Expression Classifier to Be Presented at ENDO 2016

 Veracyte, Inc. (NASDAQ: VCYT) today announced that company and external researchers will deliver poster presentations demonstrating the...


Mar 28, 2016, 08:00 ET Veracyte Secures Up to $45 Million in Financing from Visium Healthcare Partners

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, and Visium Healthcare Partners, LP,...


Mar 22, 2016, 07:30 ET New Study Supports Use of Veracyte's Medullary Thyroid Cancer Classifier as Part of Its Comprehensive Afirma Solution

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data from a large,...


Mar 16, 2016, 07:30 ET New Data Show That Veracyte's Afirma® Gene Expression Classifier Reduces Unnecessary Thyroid Surgeries and Costs During Long-Term Follow-Up

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced publication of data...


Mar 10, 2016, 16:05 ET Veracyte Announces Fourth Quarter and Full-Year 2015 Financial Results, Provides 2016 Financial Outlook

Veracyte, Inc. (NASDAQ: VCYT) today announced financial results and business progress for the quarter and full year ended December 31, 2015,...


Feb 29, 2016, 16:05 ET Veracyte Announces Publication of Data Confirming Analytical Verification of Percepta® Bronchial Genomic Classifier

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data confirming the...


Feb 25, 2016, 11:12 ET Veracyte Announces Publication of Data Supporting Clinical Utility of the Percepta® Bronchial Genomic Classifier in Lung Cancer Diagnosis

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data supporting the...


Feb 25, 2016, 08:00 ET Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2015 Financial Results on March 10

 Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its fourth quarter and full-year 2015 financial results after close of...


Jan 28, 2016, 07:30 ET Veracyte Receives Regulatory Authorization to Offer Percepta™ Bronchial Genomic Classifier for Patients in New York State

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has...


Jan 27, 2016, 08:00 ET Veracyte to Participate in Two Upcoming Investor Conferences

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Leerink...